Trial · NCT04971226
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Asciminib (Imatinib Stratum) | 101 | |
| Overall Study | STARTED | Asciminib (2nd Generation TKI Stratum) | 100 | |
| Overall Study | STARTED | Investigator Selected TKI (Imatinib Stratum) | 102 | |
| Overall Study | STARTED | Investigator Selected TKI (2nd Generation TKI Stratum | 102 | |
| Overall Study | Participants Not Treated | Asciminib (Imatinib Stratum) | 1 | |
| Overall Study | Participants Not Treated | Asciminib (2nd Generation TKI Stratum) | 0 | |
| Overall Study | Participants Not Treated | Investigator Selected TKI (Imatinib Stratum) | 2 | |
| Overall Study | Participants Not Treated | Investigator Selected TKI (2nd Generation TKI Stratum | 1 | |
| Overall Study | Treated | Asciminib (Imatinib Stratum) | 100 | |
| Overall Study | Treated | Asciminib (2nd Generation TKI Stratum) | 100 | |
| Overall Study | Treated | Investigator Selected TKI (Imatinib Stratum) | 100 | |
| Overall Study | Treated | Investigator Selected TKI (2nd Generation TKI Stratum | 101 | |
| Overall Study | COMPLETED | Asciminib (Imatinib Stratum) | 85 | |
| Overall Study | COMPLETED | Asciminib (2nd Generation TKI Stratum) | 88 | |
| Overall Study | COMPLETED | Investigator Selected TKI (Imatinib Stratum) | 63 | |
| Overall Study | COMPLETED | Investigator Selected TKI (2nd Generation TKI Stratum | 77 | |
| Overall Study | NOT COMPLETED | Asciminib (Imatinib Stratum) | 16 | |
| Overall Study | NOT COMPLETED | Asciminib (2nd Generation TKI Stratum) | 12 | |
| Overall Study | NOT COMPLETED | Investigator Selected TKI (Imatinib Stratum) | 39 | |
| Overall Study | NOT COMPLETED | Investigator Selected TKI (2nd Generation TKI Stratum | 25 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04971226/flow